gynecology

Seed Health introduces revolutionary vaginal microbiome product: VS-01

The product, based on the pioneering research of Dr. Jacques Ravel, is the first of its kind to be clinically validated for establishing an optimal vaginal microbiome, dominated by Lactobacillus…

Gut microbiota is a key player for bone health in post-menopausal women

Bone resorption increases the risk of osteopenia and osteoporosis during and after menopause – learn about the importance of the gut microbiota to support healthy bones.

Concerto Biosciences announces discovery initiative to combat recurrent vaginal yeast infections with novel live microbial product

Ensemble No.3 (ENS-003) is in development to address vulvovaginal candidiasis – a vaginal yeast infection for which antifungal treatments offer limited protection from recurrence.

Specific gut bacteria reduce ovarian cancer progression in mice

The findings of a recent study tie the gut microbiota to immune surveillance of ovarian cancer and may inform new treatment approaches.

Proge Farm receives authorisation for the gynaecological drug containing its Lactobacillus plantarum p 17630 in the EU

Important goal reached by the Novara-based pharmaceuticals company, specialised in the production and marketing of live biotherapeutic products.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top